Home Compare IONS vs SNOW
Stock Comparison · Valuation-led comparison

Ionis Pharmaceuticals vs Snowflake: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Snowflake carrying a narrow edge on valuation. The remaining gap is narrow enough that the comparison remains open to different readings. In the market, Ionis Pharmaceuticals carries the stronger setup — intact trend against Snowflake's broken trend. That leaves a split case: the structural lead stays with Snowflake, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.

Updated 2026-05-17

Most of the separation is still concentrated in valuation.

Trajectory Similarity
0.62
Moderately similar
Peer-set rank: #10
within Ionis Pharmaceuticals, Inc.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The strongest overlap appears in investment intensity and recent revenue growth.

Similarity drivers
investment intensityrecent revenue growth
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
IONS
Ionis Pharmaceuticals, Inc.
39
Peer-Score
Signal qualitylow
Peer basis: Russell 1000
vs
SNOW
Snowflake Inc.
41
Peer-Score
Signal qualitylow
Peer basis: Russell 1000

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing shapes this comparison more than a broad operating gap.

Dimension spread: IONS vs SNOW Profitability 21 21 Stability 48 44 Valuation 30 43 Growth 70 66 IONS SNOW
Gap Ranking
#1 Valuation +13
#2 Growth +4
#3 Stability +4
#4 Profitability
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for IONS and SNOW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer IONSSNOW Relative valuation Structural strength

Ionis Pharmaceuticals, Inc. and Snowflake Inc. look relatively close on structure, but the price setup still leans toward Ionis Pharmaceuticals, Inc..

Valuation position uses peer-relative valuation score and Forward P/E where available.

Entry today — historical context

Where IONS and SNOW each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY IONS Elevated · above norm 0th 50th 100th 57 pct gap SNOW Neutral · below norm 0th 50th 100th 92nd 35th
Today SNOW sits in the lower-middle of its own 5-year history (35th percentile), while IONS sits higher in its own history (92nd). Within each stock's own 5-year context, SNOW is at a historically more favourable entry position than IONS. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Valuation
Valuation also leans toward Snowflake Inc., reinforcing the broader structural lead.
Valuation — Dominant Gap
IONS
30
SNOW
43
Gap+13in favour of SNOW

The peer-relative valuation gap is visible, with the stronger side also looking meaningfully cheaper.

What keeps the gap from being one-sided

Ionis Pharmaceuticals, Inc. still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

The lead is visible, but pricing still does more of the work than the broader operating profile.

Explore full peer positioning in AssetNext

Break down the IONS vs SNOW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other close comparisons

Explore how IONS and SNOW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.